SportLinc Receives FDA Clearance: Lincotek Targets Orthopedic OEM Market
Paloma Duran
Lincotek has obtained 510(k) clearance (K252081) from the U.S. Food and Drug Administration (FDA) for its SportLinc Syndesmosis Device, a sterile, single-use implant engineered to stabilize syndesmotic trauma of the ankle. The clearance marks a key step for the company’s Medical Division as it positions the product for commercial deployment with orthopedic OEM partners. “We…